Search results
FDA Approves Nonstimulant Liquid Onyda XR for ADHD
Medscape· 10 hours agoThe centrally acting alpha2-adrenergic agonist allows for nighttime dosing and can be used with stimulants, the drug's manufacturer says.
FDA approves interchangeable biosimilar to Soliris
Becker’s Hospital Review· 1 day agoThe FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases. Bkemv is approved for the treatment of patients with paroxysmal ...
FDA issues updated Class III recall on Fiji bottled water
WJAX via Yahoo News· 14 hours agoFiji Natural Artesian Water has recalled nearly 1.9 million bottles of water after testing in March...
FDA Establishes CDER Center for Clinical Trial Innovation (C3TI)
The National Law Review· 24 hours agoFood and Drug Administration FDA establishes Center for Drug Evaluation and Research CDER Center for...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 22 hours agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
Nicotine-like chemicals in US vapes may be more potent than nicotine, FDA says - BusinessWorld...
BusinessWorld· 6 hours agoThe synthetic substances — which have a chemical structure similar to that of nicotine — are not...
FDA considers weekly insulin for diabetics - ABC Columbia
ABC Columbia· 3 days agoA U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly...
Biotech Stocks Facing FDA Decision In June 2024
RTT News· 6 hours agoNotably, in June, Eli Lilly's investigational antibody therapy Donanemab for treating early Alzheimer's will be reviewed by an advisory panel. Before delving into the drugs awaiting
FDA fast tracks lung cancer treatment by Affimed By Investing.com
Investing.com· 22 hours agoThe U.S. Food and Drug Administration (FDA) has granted Fast Track designation to a novel lung...
Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients
Gizmodo via Yahoo News· 16 hours agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...